In our study, we found that CCAT2 binds to miR-200b to suspend its inhibitory effects on IGF2BP2 expression, that resulting in elevated TK1 expression, which promoted the development of ESCC. The gene discussed is CCAT2; the disease is esophageal squamous cell carcinoma.